| Literature DB >> 32751978 |
Federico Bertoglio1,2, Lorenzo De Vita3, Agnese D'Agostino3, Yuri Diaz Fernandez4, Andrea Falqui5, Alberto Casu5, Daniele Merli3, Chiara Milanese3, Silvia Rossi6, Angelo Taglietti3, Livia Visai1,7, Piersandro Pallavicini3.
Abstract
Silver nanoparticles were produced with AgF as the starting Ag(I) salt, with pectin as the reductant and protecting agent. While the obtained nanoparticles (pAgNP-F) have the same dimensional and physicochemical properties as those already described by us and obtained from AgNO3 and pectin (pAgNP-N), the silver nanoparticles from AgF display an increased antibacterial activity against E. coli PHL628 and Staphylococcus epidermidis RP62A (S. epidermidis RP62A), both as planktonic strains and as their biofilms with respect to pAgNP-N. In particular, a comparison of the antimicrobial and antibiofilm action of pAgNP-F has been carried out with pAgNP-N, pAgNP-N and added NaF, pure AgNO3, pure AgF, AgNO3 and added NaF and pure NaNO3 and NaF salts. By also measuring the concentration of the Ag+ cation released by pAgNP-F and pAgNP-N, we were able to unravel the separate contributions of each potential antibacterial agent, observing an evident synergy between p-AgNP and the F- anion: the F- anion increases the antibacterial power of the p-AgNP solutions even when F- is just 10 µM, a concentration at which F- alone (i.e., as its Na+ salt) is completely ineffective.Entities:
Keywords: antibacterial; antibiofilm; biofilm; fluoride; ionic silver; silver nanoparticles
Mesh:
Substances:
Year: 2020 PMID: 32751978 PMCID: PMC7436145 DOI: 10.3390/molecules25153494
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1pAgNP-F sample. (A): absorbance spectrum measured in the 300–900 nm range. The inset shows the absorbance measured at a wavelength of 412 nm over time (time range: 1500 min). (B): conventional transmission electron microscopy (TEM) showing nanoparticles with spheroidal shapes. (C): High-resolution transmission electron microscopy (HRTEM) image of a single, representative polycrystalline nanoparticle, showing the {220} and {111} lattice planes of Ag, corresponding to interplanar spacings of 1.44 Å and 2.36 Å. The combinations of interplanar spacings and angular relationships are in accordance with the formation of polycrystalline nanoparticles.
Chemical-physical data for pAgNP-F and pAgNP-N.
| d (nm)a | λmax (nm) | free Ag+(ppm)d | % mass (pectin) | pHd | |
|---|---|---|---|---|---|
| pAgNP-F | 7.2(2.7) | 412 | 0.75 | 34.5 | 10.6–11.2 |
| pAgNP-N | 7.8(2.0)b | 412b | 0.78b | 38.0b | 10.5–10.9b |
astandard deviation in parenthesis; bthis work; cRef. 10; dmeasured at the end of the synthesis.
Figure 2Minimum inhibitory concentration (MIC) values for treatments on planktonic bacteria. (A): E. coli PH628, grey bars refer to the effect of ionic silver and orange bars to the effect of pAgNP, blue checkers visually evidence data for treatments containing F−; (B): same, for S. epidermidis RP62A. Insets: surviving fraction vs micromolar concentration of NaF on treatment with the pure sodium salt for E. coli PH628 (A) and S. epidermidis RP62A (B).
Figure 3Data for pre-biofilm conditions. (A): MIC values for E. coli PH628, grey bars refer to the effect of ionic silver and orange bars to the effect of pAgNP, blue checkers visually evidence data for treatments containing F−. (B): surviving fraction values for E. coli PH628 vs silver concentration; orange circles refer p-AgNP, blue outlines and/or blue solid lines (drawn to guide the eye) define treatments containing F− (see legend in figure for exact match); (C): same as (A), for S. epidermidis RP62A; (D): same as (B), for S. epidermidis RP62A.
Figure 4Scanning electron microscopy (SEM) imaging on E. coli PH628, treated with pAgNP-F and pAgNP-N in pre-biofilm conditions. (A): positive control (incubation in biofilm-inducing medium); (B): treatment with 250 µM pAgNP-F; (C): treatment with 250 µM pAgNP-N; (D–F): same as (A–C), respectively, at larger magnification.